440
Survival and toxicity of a modified GOG 172 IP chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma
Survival and toxicity of a modified GOG 172 IP chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma
Sunday, March 29, 2015: 7:00 AM
Salon C-D (Hilton Chicago)